CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas

Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis

(2020) Christian Mirian et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Analysis of CDKN2A gene alterations in recurrent and non-recurrent meningioma

(2019) Anne Guyot et al.   JOURNAL OF NEURO-ONCOLOGY

DNA methylation-based classification of central nervous system tumours

(2018) David Capper et al.   NATURE

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

(2017) Felix Sahm et al.   LANCET ONCOLOGY

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets

(2015) Felix Sahm et al.   ACTA NEUROPATHOLOGICA

TERT Promoter Mutations and Risk of Recurrence in Meningioma

(2015) Felix Sahm et al.   JNCI-Journal of the National Cancer Institute

TERT Promoter Mutations and Risk of Recurrence in Meningioma

(2015) Felix Sahm et al.   JNCI-Journal of the National Cancer Institute

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system

(2013) Christian Koelsche et al.   ACTA NEUROPATHOLOGICA

Genomic Profiling Reveals Alternative Genetic Pathways of Meningioma Malignant Progression Dependent on the Underlying NF2 Status

(2010) S. Goutagny et al.   CLINICAL CANCER RESEARCH